Literature DB >> 23159884

Human paraoxonase double mutants hydrolyze V and G class organophosphorus nerve agents.

Stephen D Kirby1, Joseph R Norris, J Richard Smith, Brian J Bahnson, Douglas M Cerasoli.   

Abstract

Variants of human paraoxonase 1 (PON1) are being developed as catalytic bioscavengers for the organophosphorus chemical warfare agents (OP). It is preferable that the new PON1 variants have broad spectrum hydrolase activities to hydrolyze both G- and V-class OPs. H115W PON1 has shown improvements over wild type PON1 in its capacity to hydrolyze some OP compounds. We improved upon these activities either by substituting a tryptophan (F347W) near the putative active site residues for enhanced substrate binding or by reducing a bulky group (Y71A) at the periphery of the putative enzyme active site. When compared to H115W alone, we found that H115W/Y71A and H115W/F347W maintained VX catalytic efficiency but showed mixed results for the capacity to hydrolyze paraoxon. Testing our double mutants against racemic sarin, we observed reduced values of K(M) for H115W/F347W that modestly improved catalytic efficiency over wild type and H115W. Contrary to previous reports, we show that H115W can hydrolyze soman, and the double mutant H115W/Y71A is nearly 4-fold more efficient than H115W for paraoxon hydrolysis. We also observed modest stereoselectivity for hydrolysis of the P(-) stereoisomer of tabun by H115W/F347W. These data demonstrate enhancements made in PON1 for the purpose of developing an improved catalytic bioscavenger to protect cholinesterase against chemical warfare agents. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23159884     DOI: 10.1016/j.cbi.2012.10.023

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  8 in total

1.  Enzymatic detoxification of organophosphorus pesticides and related toxicants.

Authors:  Karla Alejo-González; Erik Hanson-Viana; Rafael Vazquez-Duhalt
Journal:  J Pestic Sci       Date:  2018-02-28       Impact factor: 1.519

2.  Copper-Containing Catalytic Amyloids Promote Phosphoester Hydrolysis and Tandem Reactions.

Authors:  Zsófia Lengyel; Caroline M Rufo; Yurii S Moroz; Olga V Makhlynets; Ivan V Korendovych
Journal:  ACS Catal       Date:  2017-11-22       Impact factor: 13.084

Review 3.  Organophosphate-Hydrolyzing Enzymes as First-Line of Defence Against Nerve Agent-Poisoning: Perspectives and the Road Ahead.

Authors:  A R Satvik Iyengar; Abhay H Pande
Journal:  Protein J       Date:  2016-12       Impact factor: 2.371

4.  A rationally designed mutant of plasma platelet-activating factor acetylhydrolase hydrolyzes the organophosphorus nerve agent soman.

Authors:  Stephen D Kirby; Joseph Norris; Richard Sweeney; Brian J Bahnson; Douglas M Cerasoli
Journal:  Biochim Biophys Acta       Date:  2015-09-03

Review 5.  Current and emerging strategies for organophosphate decontamination: special focus on hyperstable enzymes.

Authors:  Pauline Jacquet; David Daudé; Janek Bzdrenga; Patrick Masson; Mikael Elias; Eric Chabrière
Journal:  Environ Sci Pollut Res Int       Date:  2016-02-02       Impact factor: 4.223

6.  Enzymatic neutralization of the chemical warfare agent VX: evolution of phosphotriesterase for phosphorothiolate hydrolysis.

Authors:  Andrew N Bigley; Chengfu Xu; Terry J Henderson; Steven P Harvey; Frank M Raushel
Journal:  J Am Chem Soc       Date:  2013-07-09       Impact factor: 15.419

7.  Active Site Hydrophobicity and the Convergent Evolution of Paraoxonase Activity in Structurally Divergent Enzymes: The Case of Serum Paraoxonase 1.

Authors:  David Blaha-Nelson; Dennis M Krüger; Klaudia Szeler; Moshe Ben-David; Shina Caroline Lynn Kamerlin
Journal:  J Am Chem Soc       Date:  2017-01-11       Impact factor: 15.419

8.  Development of organophosphate hydrolase activity in a bacterial homolog of human cholinesterase.

Authors:  Patricia M Legler; Susanne M Boisvert; Jaimee R Compton; Charles B Millard
Journal:  Front Chem       Date:  2014-07-16       Impact factor: 5.221

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.